Caxton Associates Background and Investment Strategies

Caxton Associates was founded in 1983 by Bruce Kovner, a renowned hedge fund manager.

The firm is headquartered in New York City, with a global presence and a strong reputation in the financial industry.

Caxton Associates is known for its global macro strategy, which involves making investments based on macroeconomic trends and events.

Bruce Kovner's investment philosophy emphasizes a long-term approach, with a focus on preserving capital and generating consistent returns.

Caxton Associates was founded in 1983 by Bruce Kovner, who trained under Michael Marcus at Commodities Corporation.

Caxton closed its fund to new investors in 1992, but reopened intermittently, with the most recent reopening happening in August 2013.

By the end of the 1990s, Caxton Global Investments' volatility had fallen, along with its returns.

In 2003, concern about the potential impact of the fund's size on its historical rate of return led to 20 percent of investors' capital being returned, leaving assets under management at $9.5 billion.

Bruce Kovner stepped back from trading in 2008 and appointed Andrew Law as Caxton's Chief Investment Officer.

Consider reading: Viking Global Investors

Caxton was founded in 1983 by Bruce Kovner, who trained under Michael Marcus at Commodities Corporation.

Bruce Kovner stepped back from trading in 2008 and appointed Andrew Law as Caxton's Chief Investment Officer.

Andrew Law joined Caxton in 2003 from Goldman Sachs, where he was Managing Director and head of FICC proprietary trading in London.

Caxton Associates has returned $12.8 billion to clients since 1983, ranking second amongst managers who have returned more than they currently manage.

In 2003, Caxton Associates returned 20% of investors' capital due to concern about the potential future impact on their historical rate of return.

The fund reopened to new investors in August 2013, after being closed intermittently since 1992.

Recommended read: Currency Trading Hedge Funds

Caxton Associates has a history of filing with the SEC, with the first available filing dating back to 2010. You can view these past filings online.

The company has consistently filed their 13F reports on a quarterly basis, with the most recent filings available for 2024 Q4 and 2024 Q3. These reports provide insight into the company's investment activities.

Caxton Associates has filed their 13F reports on the 14th of February, November, and August of each year since 2010. This suggests a consistent filing schedule.

Here is a list of the past filings by Caxton Associates:

Caxton Associates is a global macro hedge fund that has made more than $13 billion for its clients, with an annual return of around 14% and half the volatility of the S&P 500.

The fund has three core principles: listening to the markets, understanding politics and policy, and controlling risk. These principles have guided their investment decisions over the years.

Caxton Associates has made 7 investments, with their latest investment being in ProNAi Therapeutics as part of their Series D on April 17, 2014.

Here are some of their notable portfolio exits:

Caxton Associates holds 475 positions in its portfolio as reported in the December 2024 quarterly 13F filing.

Verifying employees is a crucial step in managing your investments and portfolio. Truv makes this process quick, secure, and cost-effective for thousands of verifiers.

Most employee verifications happen in under 24 hours. You only pay for successful verification.

Truv's automated system streamlines the process, making it easier and more efficient than competitors. Thousands of verifiers love Truv for its simplicity and cost savings.

Saving an average of 50% compared to competitors is a significant advantage of using Truv for employee verification.

Caxton Associates is a global macro hedge fund that has made more than $13 billion for its clients, with an annual return of roughly 14 percent and half the volatility of the S&P 500.

The firm has made significant investments over the years, with its flagship fund accounting for $7 billion of Caxton Associates assets under management.

Caxton Associates has a disciplined approach to investments, with three core principles: listening to the markets, understanding politics and policy, and maintaining risk control.

The firm's investment strategy includes arbitrage and relative value, event-driven, and directional approaches.

Worth a look: Baker Brothers Advisors

Here are some key facts about Caxton Associates' investments:

Caxton Associates has made 7 investments, with their latest investment being in ProNAi Therapeutics as part of their Series D on April 17, 2014.

The firm holds 475 positions in its portfolio, as reported in the December 2024 quarterly 13F filing.

Caxton Associates has a total of 5 portfolio exits, with their latest exit being the IPO of ProNAi Thrapeutics on July 16, 2015. This exit was valued at $XXM.

The company had another IPO exit on August 22, 2013, although the details of the exit and the company involved are not publicly available. The same is true for their IPO exits on January 23, 2010, February 6, 2007, and May 18, 2004.

Here's a breakdown of Caxton Associates' portfolio exits: